XML 46 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Acquisitions (Tables)
12 Months Ended
Jun. 30, 2020
Business Combinations [Abstract]  
Assets acquired and liabilities assumed

The Pediatric Portfolio

 

     As of  
    November 1, 2019  
Consideration      
Cash and cash equivalents   $ 4,500,000  
Fair value of Series G Convertible Preferred Stock        
Total shares issued     9,805,845  
Estimated fair value per share of Aytu common stock   $ 0.567  
      5,559,914  
         
Total consideration transferred   $ 10,059,914  
         
Recognized amounts of identifiable assets acquired and liabilities assumed        
Inventory, net   $ 459,123  
Prepaid assets     1,743,555  
Other current assets     2,525,886  
Intangible assets - product marketing rights     22,700,000  
Accrued liabilities     (300,000 )
Accrued product program liabilities     (6,683,932 )
Assumed fixed payment obligations   $ (29,837,853 )
Total identifiable net assets     (9,393,221 )
         
Goodwill   $ 19,453,135  

 

Innovus Merger (Consumer Health Portfolio)

 

     As of  
    February 14, 2020  
Consideration      
Fair value of Aytu Common Stock      
Total shares issued at close     3,810,393  
Estimated fair value per share of Aytu common stock   $ 0.756  
Estimated fair value of equity consideration transferred   $ 2,880,581  
         
Fair value of Series H Convertible Preferred Stock        
Total shares issued     1,997,736  
Estimated fair value per share of Aytu common stock   $ 0.756  
        Estimated fair value of equity consideration transferred   $ 1,510,288  
         
Fair value of former Innovus warrants   $ 15,315  
Fair value of Contingent Value Rights   $ 7,049,079  
Forgiveness of Note Payable owed to the Company   $ 1,350,000  
         
Total consideration transferred   $ 12,805,263  

 

     As of  
    February 14, 2020  
Total consideration transferred   $ 12,805,263  
         
Cash and cash equivalents   $ 390,916  
Accounts receivables, net     278,826  
Inventory, net     1,149,625  
Prepaid expenses and other current assets     1,692,133  
Other long-term assets     36,781  
Right-to-use assets     328,410  
Property, plant and equipment     190,393  
Trademarks and patents     11,744,000  
Accounts payable and accrued other expenses     (7,202,309 )
Other current liabilities     (629,601 )
Debt     (3,056,361 )
Lease liability     (754,822 )
         
Total identifiable net assets     4,167,991  
         
Goodwill   $ 8,637,272  
Reconciliation of goodwill
    Goodwill – Pediatric Portfolio  
Balance as of November 1, 2019   $ 15,387,064  
Increase due to change in estimated fixed payment obligations     3,766,071  
Increase to account for settlement with former product licensor     300,000  
Balance as of June 30, 2020   $ 19,453,135  

 

    Goodwill - Innovus Merger  
As of February 14, 2020   $ 8,374,269  
Increase due to settlements related to lawsuit and product royalties     209,178  
Increase due to additional bonus accrual     53,825  
As of June 30, 2020   $ 8,637,272  
Intangible assets acquired

The Pediatric Portfolio

  

    As of November 1, 2020  
       
Acquired product technology rights   $ 22,700,000  

 

 Innovus Merger (Consumer Health Portfolio)

 

    As of February 14, 2020  
       
Acquired product distribution rights   $ 11,354,000  
Acquired customer lists     390,000  
Total intangible assets   $ 11,744,000  
Pro forma information
    Year ended June 30,  
    2020     2019  
   

 Unaudited

(aa)

   

Pro forma

Unaudited

 
             
Total revenues, net   $ 35,562,537     $ 39,044,357  
Net loss   $ (16,325,078 )   $ (37,939,908 )
Net loss per share   $ (0.37 )   $ (3.27 )

 

(aa) Due to the absence of discrete financial information for Innovus, covering the period from February 1, 2020 through February 13, 2020, the Company did not include the impact of that stub-period for the pro forma results for the year ended June 30, 2020.